Hepalink Stocks Achieve Highest Ever Price for IPO in China's A-share Market
Published:
2010-04-26
Shenzhen Hepalink Pharmaceutical Co., Ltd., announced that shares in the company were to be issued at 148 yuan during the firms initial public offering (IPO). This is the highest issue price in the history of China's A-share market.
Source
Shanghai Securities Journal
Google Translation
Source
Shanghai Securities Journal
Google Translation
The views posted here belong to the commentor, and are not representative of the Economic Observer |
Interactive
Multimedia
A look at Nanjing local government's controversial urban reconstruction project